ReviewIndian dermatology online journal
Role of Pharmacovigilance in Drug Safety Monitoring.
Review in Indian dermatology online journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Awareness of healthcare professional students towards pharmacovigilance and adverse drug reaction reporting at a Saudi Public University.BMC health services research · 2026Article
- A prospective cross-sectional study on pharmacovigilance of antipsychotic drugs at a tertiary care teaching hospital.Bioinformation · 2026Article
- Policy text analysis of China's smart pharmaceutical regulation under a policy tool-policy stage framework.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the introduction of more and more drugs, modern medicine has succeeded in saving mankind from many fatal infections and other diseases. As newer drugs are brought into the market, the reported adverse drug events also increase. Drug safety measures include meticulous premarketing trials, post-marketing surveillance, avoidance of errors from drug prescription to administration, and ensuring the availability of quality medicines at healthcare facilities. Early diagnosis and prompt treatment of pharmacological side effects and idiosyncratic drug reactions are of utmost importance. Pharmacovigilance program helps to compile data on preventable and non-preventable adverse drug events through vigilant monitoring, utilizes the data to recommend regulations, and conveys information on potential risks associated with specific medicines to all stakeholders. The advances in technology, including artificial intelligence, offer unlimited scope to expand pharmacovigilance services. In this review, we have attempted to discuss the functioning and prospects of the pharmacovigilance program with a special focus on cutaneous adverse drug reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.